- IBDEI0JA ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,8677,0)
- ;;=D68.0^^39^401^213
- ;;^UTILITY(U,$J,358.3,8677,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8677,1,3,0)
- ;;=3^Von Willebrand's Disease
- ;;^UTILITY(U,$J,358.3,8677,1,4,0)
- ;;=4^D68.0
- ;;^UTILITY(U,$J,358.3,8677,2)
- ;;=^127267
- ;;^UTILITY(U,$J,358.3,8678,0)
- ;;=C88.0^^39^401^214
- ;;^UTILITY(U,$J,358.3,8678,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8678,1,3,0)
- ;;=3^Waldenstrom Macroglobulinemia
- ;;^UTILITY(U,$J,358.3,8678,1,4,0)
- ;;=4^C88.0
- ;;^UTILITY(U,$J,358.3,8678,2)
- ;;=^5001748
- ;;^UTILITY(U,$J,358.3,8679,0)
- ;;=C91.02^^39^401^3
- ;;^UTILITY(U,$J,358.3,8679,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8679,1,3,0)
- ;;=3^Acute Lymphoblastic Leukemia,In Relapse
- ;;^UTILITY(U,$J,358.3,8679,1,4,0)
- ;;=4^C91.02
- ;;^UTILITY(U,$J,358.3,8679,2)
- ;;=^5001764
- ;;^UTILITY(U,$J,358.3,8680,0)
- ;;=C92.02^^39^401^6
- ;;^UTILITY(U,$J,358.3,8680,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8680,1,3,0)
- ;;=3^Acute Myeloblastic Leukemia,In Relapse
- ;;^UTILITY(U,$J,358.3,8680,1,4,0)
- ;;=4^C92.02
- ;;^UTILITY(U,$J,358.3,8680,2)
- ;;=^5001791
- ;;^UTILITY(U,$J,358.3,8681,0)
- ;;=D09.3^^39^401^50
- ;;^UTILITY(U,$J,358.3,8681,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8681,1,3,0)
- ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
- ;;^UTILITY(U,$J,358.3,8681,1,4,0)
- ;;=4^D09.3
- ;;^UTILITY(U,$J,358.3,8681,2)
- ;;=^5001955
- ;;^UTILITY(U,$J,358.3,8682,0)
- ;;=C22.0^^39^401^91
- ;;^UTILITY(U,$J,358.3,8682,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8682,1,3,0)
- ;;=3^Hepatocellular Carcinoma
- ;;^UTILITY(U,$J,358.3,8682,1,4,0)
- ;;=4^C22.0
- ;;^UTILITY(U,$J,358.3,8682,2)
- ;;=^5000933
- ;;^UTILITY(U,$J,358.3,8683,0)
- ;;=C24.9^^39^401^118
- ;;^UTILITY(U,$J,358.3,8683,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8683,1,3,0)
- ;;=3^Malig Neop Biliary Tract,Unspec
- ;;^UTILITY(U,$J,358.3,8683,1,4,0)
- ;;=4^C24.9
- ;;^UTILITY(U,$J,358.3,8683,2)
- ;;=^5000942
- ;;^UTILITY(U,$J,358.3,8684,0)
- ;;=C50.922^^39^401^142
- ;;^UTILITY(U,$J,358.3,8684,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8684,1,3,0)
- ;;=3^Malig Neop Left Male Breast,Unspec Site
- ;;^UTILITY(U,$J,358.3,8684,1,4,0)
- ;;=4^C50.922
- ;;^UTILITY(U,$J,358.3,8684,2)
- ;;=^5133340
- ;;^UTILITY(U,$J,358.3,8685,0)
- ;;=C34.91^^39^401^160
- ;;^UTILITY(U,$J,358.3,8685,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8685,1,3,0)
- ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
- ;;^UTILITY(U,$J,358.3,8685,1,4,0)
- ;;=4^C34.91
- ;;^UTILITY(U,$J,358.3,8685,2)
- ;;=^5000967
- ;;^UTILITY(U,$J,358.3,8686,0)
- ;;=C50.921^^39^401^164
- ;;^UTILITY(U,$J,358.3,8686,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8686,1,3,0)
- ;;=3^Malig Neop Right Male Breast,Unspec Site
- ;;^UTILITY(U,$J,358.3,8686,1,4,0)
- ;;=4^C50.921
- ;;^UTILITY(U,$J,358.3,8686,2)
- ;;=^5001198
- ;;^UTILITY(U,$J,358.3,8687,0)
- ;;=C90.02^^39^401^176
- ;;^UTILITY(U,$J,358.3,8687,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8687,1,3,0)
- ;;=3^Multiple Myeloma,In Relapse
- ;;^UTILITY(U,$J,358.3,8687,1,4,0)
- ;;=4^C90.02
- ;;^UTILITY(U,$J,358.3,8687,2)
- ;;=^5001753
- ;;^UTILITY(U,$J,358.3,8688,0)
- ;;=D51.9^^39^401^25
- ;;^UTILITY(U,$J,358.3,8688,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,8688,1,3,0)
- ;;=3^Anemia in Vitamin B12 Deficiency
- ;;^UTILITY(U,$J,358.3,8688,1,4,0)
- ;;=4^D51.9
- ;;^UTILITY(U,$J,358.3,8688,2)
- ;;=^5002289
- ;;^UTILITY(U,$J,358.3,8689,0)
- ;;=C79.51^^39^401^35
- ;;^UTILITY(U,$J,358.3,8689,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0JA 3750 printed Feb 18, 2025@23:16:09 Page 2
- IBDEI0JA ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,8677,0)
- +2 ;;=D68.0^^39^401^213
- +3 ;;^UTILITY(U,$J,358.3,8677,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,8677,1,3,0)
- +6 ;;=3^Von Willebrand's Disease
- +7 ;;^UTILITY(U,$J,358.3,8677,1,4,0)
- +8 ;;=4^D68.0
- +9 ;;^UTILITY(U,$J,358.3,8677,2)
- +10 ;;=^127267
- +11 ;;^UTILITY(U,$J,358.3,8678,0)
- +12 ;;=C88.0^^39^401^214
- +13 ;;^UTILITY(U,$J,358.3,8678,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,8678,1,3,0)
- +16 ;;=3^Waldenstrom Macroglobulinemia
- +17 ;;^UTILITY(U,$J,358.3,8678,1,4,0)
- +18 ;;=4^C88.0
- +19 ;;^UTILITY(U,$J,358.3,8678,2)
- +20 ;;=^5001748
- +21 ;;^UTILITY(U,$J,358.3,8679,0)
- +22 ;;=C91.02^^39^401^3
- +23 ;;^UTILITY(U,$J,358.3,8679,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,8679,1,3,0)
- +26 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
- +27 ;;^UTILITY(U,$J,358.3,8679,1,4,0)
- +28 ;;=4^C91.02
- +29 ;;^UTILITY(U,$J,358.3,8679,2)
- +30 ;;=^5001764
- +31 ;;^UTILITY(U,$J,358.3,8680,0)
- +32 ;;=C92.02^^39^401^6
- +33 ;;^UTILITY(U,$J,358.3,8680,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,8680,1,3,0)
- +36 ;;=3^Acute Myeloblastic Leukemia,In Relapse
- +37 ;;^UTILITY(U,$J,358.3,8680,1,4,0)
- +38 ;;=4^C92.02
- +39 ;;^UTILITY(U,$J,358.3,8680,2)
- +40 ;;=^5001791
- +41 ;;^UTILITY(U,$J,358.3,8681,0)
- +42 ;;=D09.3^^39^401^50
- +43 ;;^UTILITY(U,$J,358.3,8681,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,8681,1,3,0)
- +46 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
- +47 ;;^UTILITY(U,$J,358.3,8681,1,4,0)
- +48 ;;=4^D09.3
- +49 ;;^UTILITY(U,$J,358.3,8681,2)
- +50 ;;=^5001955
- +51 ;;^UTILITY(U,$J,358.3,8682,0)
- +52 ;;=C22.0^^39^401^91
- +53 ;;^UTILITY(U,$J,358.3,8682,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,8682,1,3,0)
- +56 ;;=3^Hepatocellular Carcinoma
- +57 ;;^UTILITY(U,$J,358.3,8682,1,4,0)
- +58 ;;=4^C22.0
- +59 ;;^UTILITY(U,$J,358.3,8682,2)
- +60 ;;=^5000933
- +61 ;;^UTILITY(U,$J,358.3,8683,0)
- +62 ;;=C24.9^^39^401^118
- +63 ;;^UTILITY(U,$J,358.3,8683,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,8683,1,3,0)
- +66 ;;=3^Malig Neop Biliary Tract,Unspec
- +67 ;;^UTILITY(U,$J,358.3,8683,1,4,0)
- +68 ;;=4^C24.9
- +69 ;;^UTILITY(U,$J,358.3,8683,2)
- +70 ;;=^5000942
- +71 ;;^UTILITY(U,$J,358.3,8684,0)
- +72 ;;=C50.922^^39^401^142
- +73 ;;^UTILITY(U,$J,358.3,8684,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,8684,1,3,0)
- +76 ;;=3^Malig Neop Left Male Breast,Unspec Site
- +77 ;;^UTILITY(U,$J,358.3,8684,1,4,0)
- +78 ;;=4^C50.922
- +79 ;;^UTILITY(U,$J,358.3,8684,2)
- +80 ;;=^5133340
- +81 ;;^UTILITY(U,$J,358.3,8685,0)
- +82 ;;=C34.91^^39^401^160
- +83 ;;^UTILITY(U,$J,358.3,8685,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,8685,1,3,0)
- +86 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
- +87 ;;^UTILITY(U,$J,358.3,8685,1,4,0)
- +88 ;;=4^C34.91
- +89 ;;^UTILITY(U,$J,358.3,8685,2)
- +90 ;;=^5000967
- +91 ;;^UTILITY(U,$J,358.3,8686,0)
- +92 ;;=C50.921^^39^401^164
- +93 ;;^UTILITY(U,$J,358.3,8686,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,8686,1,3,0)
- +96 ;;=3^Malig Neop Right Male Breast,Unspec Site
- +97 ;;^UTILITY(U,$J,358.3,8686,1,4,0)
- +98 ;;=4^C50.921
- +99 ;;^UTILITY(U,$J,358.3,8686,2)
- +100 ;;=^5001198
- +101 ;;^UTILITY(U,$J,358.3,8687,0)
- +102 ;;=C90.02^^39^401^176
- +103 ;;^UTILITY(U,$J,358.3,8687,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,8687,1,3,0)
- +106 ;;=3^Multiple Myeloma,In Relapse
- +107 ;;^UTILITY(U,$J,358.3,8687,1,4,0)
- +108 ;;=4^C90.02
- +109 ;;^UTILITY(U,$J,358.3,8687,2)
- +110 ;;=^5001753
- +111 ;;^UTILITY(U,$J,358.3,8688,0)
- +112 ;;=D51.9^^39^401^25
- +113 ;;^UTILITY(U,$J,358.3,8688,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,8688,1,3,0)
- +116 ;;=3^Anemia in Vitamin B12 Deficiency
- +117 ;;^UTILITY(U,$J,358.3,8688,1,4,0)
- +118 ;;=4^D51.9
- +119 ;;^UTILITY(U,$J,358.3,8688,2)
- +120 ;;=^5002289
- +121 ;;^UTILITY(U,$J,358.3,8689,0)
- +122 ;;=C79.51^^39^401^35
- +123 ;;^UTILITY(U,$J,358.3,8689,1,0)
- +124 ;;=^358.31IA^4^2